image
Healthcare - Biotechnology - NASDAQ - US
$ 9.63
-13.6 %
$ 477 M
Market Cap
-1.92
P/E
BALANCE SHEET
574 M ASSETS
-31.12%
262 M LIABILITIES
-17.30%
312 M EQUITY
-39.61%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition REGENXBIO Inc.
image
Current Assets 335 M
Cash & Short-Term Investments 275 M
Receivables 26.3 M
Other Current Assets 33.4 M
Non-Current Assets 239 M
Long-Term Investments 41.6 M
PP&E 193 M
Other Non-Current Assets 4.81 M
Current Liabilities 130 M
Accounts Payable 22.8 M
Short-Term Debt 14.1 M
Other Current Liabilities 93.3 M
Non-Current Liabilities 132 M
Long-Term Debt 82.2 M
Other Non-Current Liabilities 49.7 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 34.5 97.0 345.2 338.4 69.5 75.6 46.7 24.8 54.1 1.1 1.1
Short Term Investments 240.7 267.7 112.2 137.3 226.7 244.2 114.1 64.7 60.0 0 0
Receivables 26.3 28.1 32.4 43.0 38.1 8.6 0.5 1.0 2.1 1.9 1.1
Inventory 0 13.9 18.8 10.5 6.5 5.7 5.3 1.8 1.0 0 0
Other Current Assets 33.4 23.3 28.9 12.5 10.7 9.6 6.7 2.8 1.9 28 K 0
Total Current Assets 335.0 416.0 518.8 531.2 345.0 337.9 168.0 93.4 118.1 3.0 2.2
PP&E 192.6 206.8 192.5 120.3 39.1 28.7 14.0 9.3 0.5 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 41.6 200.6 391.9 46.8 103.8 150.8 15.6 69.4 102.5 0.3 0.3
Other Long Term Assets 4.8 9.9 10.7 9.9 10.0 26.4 1.1 0.6 0.2 0.2 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 574.0 833.3 1 113.9 708.2 497.9 543.8 198.7 172.7 221.4 3.5 2.5
LIABILITIES
Accounts Payable 22.8 27.2 11.4 10.6 6.4 4.4 4.8 1.5 1.0 0.3 0.3
Short Term Debt 14.1 12.0 3.5 5.0 4.8 0 0 0 0 3.8 0.7
Other Current Liabilities 93.2 89.4 100.9 62.2 22.4 16.4 9.6 8.1 3.2 5.0 3.7
Total Current Liabilities 130.3 130.4 130.5 81.4 33.7 22.2 14.4 9.7 4.3 9.2 4.7
Long Term Debt 82.2 88.8 84.9 70.2 8.9 5.9 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 1.1 0 0 0 0 0
Other Liabilities 49.7 97.8 134.2 175.0 1.8 3.6 1.2 1.3 0.2 0 0
Total Liabilities 262.2 317.1 349.6 330.4 47.7 35.0 15.6 11.0 4.6 9.2 4.7
EQUITY
Common Stock 4 K 4 K 4 K 4 K 4 K 4 K 3 K 3 K 3 K 0 10.9
Retained Earnings (705.0) (441.6) (161.2) (289.1) (177.8) (83.0) (187.8) (114.6) (51.6) (28.8) (24.8)
Other Accumulative Comprehensive Income/Loss (4.4) (15.4) (2.6) (0.4) 0.2 (0.7) (0.7) 33 K (0.7) 0 0
Total Equity 311.7 516.2 764.3 377.8 450.2 508.8 183.0 161.7 216.8 (5.7) (2.1)
Total Liabilities and Equity 574.0 833.3 1 113.9 708.2 497.9 543.8 198.7 172.7 221.4 3.5 2.5
SHARES OUTSTANDING
Common Shares Outstanding 43.7 43.2 42.4 37.3 36.7 36.6 29.9 26.4 9.2 13.1 13.1